A Different Perspective While Beta Drugs shareholders are down 19% for the year, the market itself is up 0.8%. However, keep in mind that even the best stocks will sometimes underperform the market ...

Major players in the antiglaucoma drugs market are Aerie Pharmaceuticals, Inc. , Allergan, Novartis AG, Abbott Healthcare, Johnson & Johnson, Merck & Co. , Genentech ...

The board of Beta Drugs Limited (“Beta Drugs” or “Company”), a fast-growing oncology focused formulations company, has approved preferential allotment of 707,651 Compulsorily Convertible ...

Beta Drugs, a vertically integrated oncology-focused pharmaceutical company, has raised INR 117 crore in primary capital from HealthQuad Fund II (HealthQuad), alongside a Singapore-based ...